EP2097439 - PEPTIDES [Right-click to bookmark this link] | |||
Former [2009/37] | NOVEL PEPTIDES | ||
[2012/39] | Status | No opposition filed within time limit Status updated on 03.01.2014 Database last updated on 31.08.2024 | Most recent event Tooltip | 04.09.2015 | Lapse of the patent in a contracting state New state(s): MT | published on 07.10.2015 [2015/41] | Applicant(s) | For all designated states Faron Ventures OY Tykistökatu 6 B 20520 Turku / FI | [2009/37] | Inventor(s) | 01 /
KIVI, Elina Zähringer Strasse 303 79108 Freiburg / DE | 02 /
ELIMA, Kati Metsäpirtinkatu 25 20740 Turku / FI | 03 /
JALKANEN, Sirpa Rauvolantie 79 20760 Piispanristi / FI | [2009/43] |
Former [2009/37] | 01 /
KIVI, Elina Itäinen Pitkäkatu 10 A 7 20520 Turku / FI | ||
02 /
ELIMA, Kati Metsäpirtinkatu 25 20740 Turku / FI | |||
03 /
JALKANEN, Sirpa Rauvolantie 79 20760 Piispanristi / FI | Representative(s) | Öhman, Ann-Marie Kaivokatu 15 B 23 20520 Turku / FI | [2013/09] |
Former [2009/37] | Öhman, Ann-Marie Kaivokatu 15 B 23 20520 Turku / FI | Application number, filing date | 07858320.0 | 18.12.2007 | [2009/37] | WO2007FI00296 | Priority number, date | FI20060001156 | 27.12.2006 Original published format: FI 20061156 | [2009/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008077993 | Date: | 03.07.2008 | Language: | EN | [2008/27] | Type: | A1 Application with search report | No.: | EP2097439 | Date: | 09.09.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application. | [2009/37] | Type: | B1 Patent specification | No.: | EP2097439 | Date: | 27.02.2013 | Language: | EN | [2013/09] | Search report(s) | International search report - published on: | FI | 03.07.2008 | (Supplementary) European search report - dispatched on: | EP | 06.05.2011 | Classification | IPC: | C07K7/06, C07K14/47, A61K38/08, A61K49/00, G01N33/53, G01N33/68, C12N9/06 | [2009/37] | CPC: |
B82Y5/00 (EP,US);
A61K47/66 (EP,US);
A61K47/64 (EP,US);
A61P21/00 (EP);
A61P29/00 (EP);
A61P37/00 (EP);
A61P43/00 (EP);
C07K14/705 (EP,US);
C07K7/06 (EP,US);
A61K38/00 (EP,US);
G01N2800/042 (EP,US);
G01N2800/24 (EP,US);
G01N2800/32 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/37] | Title | German: | PEPTIDE | [2013/08] | English: | PEPTIDES | [2013/08] | French: | PEPTIDES | [2013/08] |
Former [2009/37] | NEUE PEPTIDE | ||
Former [2009/37] | NOVEL PEPTIDES | ||
Former [2009/37] | NOUVEAUX PEPTIDES | Entry into regional phase | 04.05.2009 | National basic fee paid | 04.05.2009 | Search fee paid | 04.05.2009 | Designation fee(s) paid | 04.05.2009 | Examination fee paid | Examination procedure | 04.05.2009 | Examination requested [2009/37] | 06.10.2011 | Amendment by applicant (claims and/or description) | 28.10.2011 | Despatch of a communication from the examining division (Time limit: M06) | 14.03.2012 | Reply to a communication from the examining division | 13.07.2012 | Despatch of a communication from the examining division (Time limit: M02) | 11.08.2012 | Reply to a communication from the examining division | 16.10.2012 | Communication of intention to grant the patent | 09.01.2013 | Fee for grant paid | 09.01.2013 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.10.2011 | Opposition(s) | 28.11.2013 | No opposition filed within time limit [2014/06] | Fees paid | Renewal fee | 23.12.2009 | Renewal fee patent year 03 | 17.12.2010 | Renewal fee patent year 04 | 20.12.2011 | Renewal fee patent year 05 | 13.12.2012 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 18.12.2007 | AT | 27.02.2013 | BE | 27.02.2013 | CY | 27.02.2013 | CZ | 27.02.2013 | DK | 27.02.2013 | EE | 27.02.2013 | FI | 27.02.2013 | IT | 27.02.2013 | LT | 27.02.2013 | LV | 27.02.2013 | MC | 27.02.2013 | MT | 27.02.2013 | NL | 27.02.2013 | PL | 27.02.2013 | RO | 27.02.2013 | SE | 27.02.2013 | SI | 27.02.2013 | SK | 27.02.2013 | TR | 27.02.2013 | BG | 27.05.2013 | GR | 28.05.2013 | ES | 07.06.2013 | IS | 27.06.2013 | PT | 27.06.2013 | [2015/41] |
Former [2015/34] | HU | 18.12.2007 | |
AT | 27.02.2013 | ||
BE | 27.02.2013 | ||
CY | 27.02.2013 | ||
CZ | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
IT | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
MC | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
RO | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
SK | 27.02.2013 | ||
TR | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2015/32] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
CY | 27.02.2013 | ||
CZ | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
IT | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
MC | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
RO | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
SK | 27.02.2013 | ||
TR | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2014/38] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
CY | 27.02.2013 | ||
CZ | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
IT | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
MC | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
RO | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
SK | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2014/03] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
CY | 27.02.2013 | ||
CZ | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
IT | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
RO | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
SK | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2013/52] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
CY | 27.02.2013 | ||
CZ | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
RO | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
SK | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2013/49] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
CZ | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
RO | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
SK | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2013/48] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
DK | 27.02.2013 | ||
EE | 27.02.2013 | ||
FI | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
NL | 27.02.2013 | ||
PL | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2013/40] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
FI | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
PL | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
PT | 27.06.2013 | ||
Former [2013/38] | AT | 27.02.2013 | |
BE | 27.02.2013 | ||
FI | 27.02.2013 | ||
LT | 27.02.2013 | ||
LV | 27.02.2013 | ||
PL | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
Former [2013/37] | AT | 27.02.2013 | |
FI | 27.02.2013 | ||
LT | 27.02.2013 | ||
PL | 27.02.2013 | ||
SE | 27.02.2013 | ||
SI | 27.02.2013 | ||
BG | 27.05.2013 | ||
GR | 28.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
Former [2013/36] | AT | 27.02.2013 | |
LT | 27.02.2013 | ||
PL | 27.02.2013 | ||
SE | 27.02.2013 | ||
BG | 27.05.2013 | ||
ES | 07.06.2013 | ||
IS | 27.06.2013 | ||
Former [2013/34] | LT | 27.02.2013 | |
SE | 27.02.2013 | ||
BG | 27.05.2013 | ||
IS | 27.06.2013 | ||
Former [2013/33] | LT | 27.02.2013 | Documents cited: | Search | [A] - BONO P ET AL, "Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 JUN 1998, (19980601), vol. 160, no. 11, ISSN 0022-1767, pages 5563 - 5571, XP002558724 [A] 1,12-15 * the whole document * | [A] - TAKEDA SOICHI ET AL, "Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, (200606), vol. 25, no. 11, ISSN 0261-4189, pages 2388 - 2396, XP002558725 [A] 1,12-15 * the whole document * DOI: http://dx.doi.org/10.1038/SJ.EMBOJ.7601131 | International search | [A]WO2006128951 (FARON PHARMACEUTICALS OY [FI], et al); | [A] - VAINIO P.J. ET AL., "Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis", BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, (200506), vol. 96, no. 6, pages 429 - 435, XP008106108 DOI: http://dx.doi.org/10.1111/j.1742-7843.2005.pto_96605.x | [A] - JAAKKOLA K. ET AL., "In vivo detection of vascular adhesion protein-1 in experimental inflammation", AMERICAN JOURNAL OF PATHOLOGY, (200008), vol. 157, no. 2, pages 463 - 471, XP001197363 | [A] - WANG E.Y. ET AL., "Design, synthesis, and biologcial evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity", JOURNAL OF MEDICINAL CHEMISTRY, (200604), vol. 49, no. 7, pages 2166 - 2173, XP008106109 DOI: http://dx.doi.org/10.1021/jm050538l | Examination | - K. AALTO ET AL, "Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer", BLOOD, (20110929), vol. 118, no. 13, doi:10.1182/blood-2010-09-311076, ISSN 0006-4971, pages 3725 - 3733, XP055035983 DOI: http://dx.doi.org/10.1182/blood-2010-09-311076 | by applicant | - R OLIYAI; VJ STELLA, ANNU. REV. PHARMACOL. TOXICOL., (1993), vol. 32, pages 521 - 44 |